TRIFIRO', Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 9.051
AS - Asia 5.930
EU - Europa 4.000
SA - Sud America 906
AF - Africa 132
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 1
Totale 20.036
Nazione #
US - Stati Uniti d'America 8.905
SG - Singapore 2.371
HK - Hong Kong 1.737
CN - Cina 996
IE - Irlanda 841
BR - Brasile 806
RU - Federazione Russa 773
FR - Francia 647
IT - Italia 482
DE - Germania 461
KR - Corea 324
SE - Svezia 195
VN - Vietnam 188
GB - Regno Unito 181
FI - Finlandia 154
CA - Canada 91
NL - Olanda 76
IN - India 72
TG - Togo 47
AT - Austria 41
TR - Turchia 41
PL - Polonia 38
AR - Argentina 32
JP - Giappone 28
BD - Bangladesh 27
ES - Italia 24
ID - Indonesia 24
MX - Messico 23
ZA - Sudafrica 23
IQ - Iraq 19
EC - Ecuador 16
AU - Australia 15
PK - Pakistan 15
UA - Ucraina 15
SA - Arabia Saudita 14
BE - Belgio 13
AE - Emirati Arabi Uniti 10
JM - Giamaica 10
MA - Marocco 10
AZ - Azerbaigian 9
CL - Cile 9
EG - Egitto 9
GR - Grecia 9
PE - Perù 9
BO - Bolivia 8
KE - Kenya 8
UY - Uruguay 8
UZ - Uzbekistan 8
CO - Colombia 7
IR - Iran 6
VE - Venezuela 6
CH - Svizzera 5
DZ - Algeria 5
IL - Israele 5
SK - Slovacchia (Repubblica Slovacca) 5
TN - Tunisia 5
BG - Bulgaria 4
GE - Georgia 4
JO - Giordania 4
LT - Lituania 4
MD - Moldavia 4
NI - Nicaragua 4
NP - Nepal 4
PY - Paraguay 4
RO - Romania 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
BY - Bielorussia 3
DK - Danimarca 3
GH - Ghana 3
HU - Ungheria 3
LC - Santa Lucia 3
NG - Nigeria 3
TW - Taiwan 3
AL - Albania 2
BB - Barbados 2
EE - Estonia 2
ET - Etiopia 2
GT - Guatemala 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
KZ - Kazakistan 2
LY - Libia 2
NO - Norvegia 2
OM - Oman 2
PT - Portogallo 2
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BJ - Benin 1
BN - Brunei Darussalam 1
CD - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
CR - Costa Rica 1
CV - Capo Verde 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
Totale 20.009
Città #
Dallas 4.813
Hong Kong 1.731
Singapore 1.046
Dublin 839
Chandler 540
Ashburn 316
Lawrence 255
Princeton 255
Jacksonville 247
Sindelfingen 236
Wilmington 187
Beijing 151
Verona 150
Seattle 141
Los Angeles 132
Redondo Beach 124
Buffalo 114
Southend 94
Dong Ket 92
New York 88
Helsinki 77
Dongguan 72
Munich 66
Santa Clara 62
São Paulo 62
Columbus 59
The Dalles 59
Woodbridge 48
Lomé 47
Boardman 46
Amsterdam 45
Toronto 45
San Francisco 41
Turku 40
Nuremberg 35
Ho Chi Minh City 33
Norwalk 33
Chicago 32
Brooklyn 30
Washington 28
Seoul 27
Tokyo 26
Warsaw 26
Fairfield 25
Guangzhou 25
London 24
Rio de Janeiro 24
Redmond 23
Rome 23
Belo Horizonte 22
Jinan 21
Milan 21
Tianjin 21
Falkenstein 20
Lappeenranta 20
Vienna 20
Changsha 19
Council Bluffs 19
Hangzhou 18
Hanoi 18
Jakarta 18
Johannesburg 18
Ann Arbor 17
Campinas 17
Catania 16
Frankfurt am Main 16
Shanghai 16
Moscow 14
Taizhou 14
Chennai 13
Chions 13
Hamilton 13
Montreal 13
Shenyang 13
Florence 12
Mexico City 12
Nanjing 12
San Diego 12
Bologna 10
Kochi 10
Ankara 9
Brasília 9
Charlotte 9
Curitiba 9
Guarulhos 9
Kingston 9
Menlo Park 9
Paris 9
Porto Alegre 9
Riyadh 9
Zhengzhou 9
Atlanta 8
Baku 8
Boston 8
Brussels 8
Clearwater 8
Haikou 8
Hefei 8
Istanbul 8
Jiaxing 8
Totale 13.403
Nome #
1. Real World Evidence vs. Real World Data: definizioni e razionale 3.707
The Role of European Healthcare Databases for Post-Marketing Drug Effectiveness, Safety and Value Evaluation: Where Does Italy Stand? 1.068
Frequency of anticholinergic drug use in patients treated with aripiprazole once-monthly: a 2-year cohort study using European healthcare databases 217
Safety Profile of Antiviral Therapies for the Early Treatment/Prevention of COVID-19: Analysis of the International Pharmacovigilance Database VigiBase 166
Safety of Biologic Therapies for Severe Asthma: An Analysis of Adverse Reactions Reported in the WHO Pharmacovigilance Database 163
Adverse drug events in emergency department population: a prospective Italian study. 124
Allergic Reactions to COVID-19 Vaccines: Risk Factors, Frequency, Mechanisms and Management 118
Adverse drug reactions associated with off-label use of ketorolac, with particular focus on elderly patients. An analysis of the Italian pharmacovigilance database and a population based study 115
12. Real World Evidence nelle valutazioni post‑marketing su farmaci generici e biosimilari 113
COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety 109
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project 107
Antipsychotic drug exposure and risk of pneumonia: a systematic review and meta-analysis of observational studies 103
Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research 99
Anti-VEGF and Other Novel Therapies for Neovascular Age-Related Macular Degeneration: An Update 92
Safety and potential interaction of immunosuppressive drugs for the treatment of inflammatory bowel disease in elderly patients 90
Safety Assessment of Biologics for Immune-Mediated Inflammatory Diseases Using Italian VALORE Healthcare Database Network and National Spontaneous Reporting System 89
COVID-19 Patient Management in Outpatient Setting: A Population-Based Study from Southern Italy 87
Anti-hypertensive drugs deprescribing: an updated systematic review of clinical trials 86
Are Patients with Psoriasis and Psoriatic Arthritis Undertreated? A Population-Based Study from Southern Italy 85
Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study 84
Overview of the European post-authorisation study register post-authorization studies performed in Europe from September 2010 to December 2018 82
A New Era of Pharmacovigilance: Future Challenges and Opportunities 79
Agreement of Different Drug-Drug Interaction Checkers for Proton Pump Inhibitors 78
Challenges for Drug Repurposing in the COVID-19 Pandemic Era 77
Drug-induced Urinary Retention: An Analysis of a National Spontaneous Adverse Drug Reaction Reporting Database 77
Antidepressant drugs: prevalence, incidence and indication of use in general practice of Southern Italy during the years 2003-2004 76
Adherence to gastroprotection during cyclooxygenase-2 inhibitor use and the risk of upper gastrointestinal events: A population-based study 76
Assessment of intravitreal anti-VEGF drugs and dexamethasone for retinal diseases in real world setting: A multi-centre prospective study from Southern Italy 76
The role of real-world evidence for the study of rare diseases epidemiology and the post-marketing evaluation of orphan drugs 74
Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives 74
Global Cushing’s disease epidemiology: a systematic review and meta-analysis of observational studies 73
Absorbable phosphate in medication 72
Safety profile of biological medicines as compared with non-biologicals: an analysis of the italian spontaneous reporting system database. 71
Academic output from EU-funded health research projects 71
A case of lung injury resembling diffuse pulmonary hemorrhage after the first administration of alemtuzumab in a patient with multiple sclerosis. Role of the HRCT 71
Switching patterns of biological drugs in patients with psoriasis and psoriatic arthritis: insight from the VALORE database network 70
Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines 70
An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting 69
Development and testing of diagnostic algorithms to identify patients with acromegaly in Southern Italian claims databases 69
Safety profile of immune checkpoint inhibitors: An analysis of the Italian spontaneous reporting system database 69
Multidimensional Design and Analysis of a Data Mart Related to Healthcare Treatments with Biologic Drugs 68
Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy 67
Clinical impact of medication review and deprescribing in older inpatients: A systematic review and meta-analysis 67
A Reference Standard for Evaluation of Methods for Drug Safety Signal Detection using Electronic Healthcare Records (EHR) Databases 67
Adherence to Antidepressants and Mortality in Elderly Patients with Cardiovascular Disease 67
Adherence of Elderly Patients with Cardiovascular Disease to Statins and the Risk of Exacerbation of Chronic Obstructive Pulmonary Disease: Evidence from an Italian Real-World Investigation 66
Withdrawal syndrome following discontinuation of 28 antidepressants: pharmacovigilance analysis of 31,688 reports from the WHO spontaneous reporting database 64
Acute cerebellar ataxia following meningococcal group C conjugate vaccination 64
Age-related changes in pharmacodynamics: focus on drug acting on cetral nervous and cardiovascular systems 64
Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study 63
Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001 - 2012. 63
Global epidemiology of acromegaly: a systematic review and meta-analysis 63
Kidney Disease in Diabetic Patients: From Pathophysiology to Pharmacological Aspects with a Focus on Therapeutic Inertia 63
Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy 62
Direct healthcare costs of chronic kidney disease management in Italy: What cost‐savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis‐stimulating agents? 62
Adverse drug reaction-related hospitalizations in persons aged 55 years and over: a population-based study in The Netherlands 62
Acid sphingomyelinase deficiency (ASMD): addressing knowledge gaps in unmet needs and patient journey in Italy-a Delphi consensus 61
Post-Marketing Surveillance of CAR-T-Cell Therapies: Analysis of the FDA Adverse Event Reporting System (FAERS) Database 61
Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database 61
Tolerability of antipsychotics in children and adolescents: a prospective study 61
Measuring the Effectiveness of Safety Warnings on the Risk of Stroke in Older Antipsychotic Users: A Nationwide Cohort Study in Two Large Electronic Medical Records Databases in the United Kingdom and Italy 60
A nationwide prospective study on prescribing pattern of antidepressant drugs in Italian primary care 60
A semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European eu-ADR project 60
Analgesic drug use in elderly persons: A population-based study in Southern Italy 59
Safety of COVID-19 Vaccines Among the Paediatric Population: Analysis of the European Surveillance Systems and Pivotal Clinical Trials 58
Is PEGylation of Drugs Associated with Hypersensitivity Reactions? An Analysis of the Italian National Spontaneous Adverse Drug Reaction Reporting System 58
Newer and older antiepileptic drug use in Southern Italy: a population-based study during the years 2003-2005 58
Drug-induced acute myocardial infarction: identifying 'prime suspects' from electronic healthcare records-based surveillance system 58
All-cause mortality and antipsychotic use among elderly persons with high baseline cardiovascular and cerebrovascular risk: a multi-center retrospective cohort study in Italy 58
Prescribing Pattern of Drugs in the Treatment of Osteoarthritis before and after Rofecoxib Withdrawal in General Practice of Souther Italy 57
The EU-ADR project: preliminary results and perspective 57
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients 57
Design and evaluation of a semantic approach for the homogeneous identification of events in eight patient databases: a contribution to the European EU-ADR project 57
Dati regionali e loro ruolo nella pianificazione, nella programmazione e nel controllo a livello regionale 56
Effectiveness and Safety of Switching Originator and Biosimilar Epoetins in Patients with Chronic Kidney Disease in a Large-Scale Italian Cohort Study 56
Additional risk minimisation measures in the EU - are they eligible for assessment? 56
Risk minimization activities of centrally authorized products in the EU: a descriptive study 56
From Inception to ConcePTION: Genesis of a Network to Support Better Monitoring and Communication of Medication Safety During Pregnancy and Breastfeeding 56
The value of the polypill in cardiovascular disease: an Italian multidisciplinary Delphi panel consensus 55
Biosimilars in Italy: what do real-world data reveal? 54
Homecare for patients with heart failure in Italy 54
All-cause mortality associated with atypical and typical antipsychotics in demented outpatients 54
Anaphylaxis due to antiallergic and antiasthmatic biologics 53
Using the Multidimensional Prognostic Index (MPI) to improve cost-effectiveness of interventions in multimorbid frail older persons: results and final recommendations from the MPI_AGE European Project 53
Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy 53
Suspected adverse reactions to medications and food supplements containing Serenoa repens: A worldwide analysis of pharmacovigilance and phytovigilance spontaneous reports 52
Myasthenia Gravis Treatment: From Old Drugs to Innovative Therapies with a Glimpse into the Future 52
No evidence for association of azithromycin and ventricular arrhythmia: a European multi-database, population-based study of 28 million individuals 52
'Use of Antipsychotics in Children and Adolescents: A Picture From the ARITMO Population-Based European Cohort Study' 52
Global epidemiology of pheochromocytoma: a systematic review and meta-analysis of observational studies 51
Choosing Among Common Data Models for Real-World Data Analyses Fit for Making Decisions About the Effectiveness of Medical Products 51
Lipid-lowering drug use in general practice of Southern Italy: Effects of reimbursement criteria revision 51
Prescribing Patterns of Antiepileptic Drugs and Interaction Risk In General Practice 51
Interaction risk with proton pump inhibitors in general practice: Significant disagreement between different drug-related information sources 51
Traceability of Pediatric Antibiotic Purchasing Pathways in Italy: A Nationwide Real-World Drug Utilization Analysis 51
Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations 51
Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical-Experimental, and Real-World Evidence 51
Parkinsonism and severe hypothyroidism in an elderly patient: a case of lithium toxicity due to pharmacological interactions 50
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 50
“Newer and older antiepileptic drug in southern Italy: a population based study during the years 2003-2005” 50
Totale 11.751
Categoria #
all - tutte 90.729
article - articoli 80.710
book - libri 0
conference - conferenze 4.574
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 5.445
Totale 181.458


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021669 0 0 0 3 9 5 0 4 285 5 239 119
2021/20221.190 49 256 5 28 41 8 14 103 58 43 145 440
2022/20232.697 294 148 347 472 115 850 15 132 201 16 65 42
2023/20242.154 61 107 278 310 159 282 176 179 23 122 264 193
2024/20255.514 335 326 197 965 232 222 137 265 977 435 431 992
2025/20268.126 1.211 3.043 3.744 128 0 0 0 0 0 0 0 0
Totale 20.558